Page 2 - Ligand Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

SUZHOU, China, Dec. 21, 2021 /PRNewswire/ CStone Pharmaceuticals (the 'Company' or 'CStone') is pleased to announce that the National Medical

Jason yangCaicun zhouFrank jiangU ligand corporationPrnewswire cstone pharmaceuticals the companyDrug administrationNational medical products administrationShareholders of the companyDepartment of oncologyOncology trendsPrincipal investigatorShanghai pulmonary hospitalChief medical officerLigand corporationGreater chinaProffered paper oral presentation

CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER

SUZHOU, China, Dec. 21, 2021 /PRNewswire/ CStone Pharmaceuticals (the

Jason yangCaicun zhouFrank jiangU ligand corporationPrnewswire cstone pharmaceuticals the companyDrug administrationNational medical products administrationShareholders of the companyDepartment of oncologyOncology trendsPrincipal investigatorShanghai pulmonary hospitalChief medical officerLigand corporationGreater chinaProffered paper oral presentation

EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa

EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesAkram bouchenakiDan budwickMelanie nallicheriHansoh pharmaAbdul latif jameelCstone pharmaceuticalsWorld health organizationCm life sciencesU ligand corporationInternational agency for research on cancerNational medical products administrationAbdul latif jameel healthEqrx incAbdul latif

EQRx and NHSE Sign Memorandum of Understanding to Enter into England s First Population Health Partnership for Cancer Drugs

Provides roadmap to commercial agreement based on shared objective to secure patient access to innovative and cost-effective cancer medicines Agreement with one of the largest public healthcare

New yorkUnited statesUnited kingdomDan budwickKostenloser wertpapierhandelMelanie nallicheriJohn bellHansoh pharmaToxicology centreNational health serviceEqrx incScottish medicines consortiumCstone pharmaceuticalsUniversity of oxfordCm life sciencesRegulatory agency

CStone Announces the First-in-Class Registrational Clinical Trial of Sugemalimab Met its Primary Endpoint in Stage III NSCLC and Plans to Submit a New Drug Application

Sugemalimab becomes the world s first anti-PD-1/PD-L1 monoclonal antibody to successfully improve progression-free survival (PFS) in patients with stage III.

Jason yangFrank jiangCstone pharmaceuticalsSource cstone pharmaceuticalsDrug administrationData monitoring committeeU ligand corporationInternational agency for research on cancerNational medical products administration of chinaNational medical products administrationNew drug applicationBlinded independent central reviewGuangdong provincial peopleLeading principal investigatorChief medical officerGreater china